Tegaserod does not alter fasting or meal-induced biliary tract motility.
Fisher RS, Thistle J, Lembo A, Novick J, O'Kane P, Chey WD, Beglinger C, Rueegg P, Shi V, Dogra A, Luo D, Earnest DL.
Fisher RS, et al. Among authors: chey wd.
Am J Gastroenterol. 2004 Jul;99(7):1342-9. doi: 10.1111/j.1572-0241.2004.30301.x.
Am J Gastroenterol. 2004.
PMID: 15233676
Free article.
Clinical Trial.